Treatment of vertebrobasilar insufficiency-associated vertigo with a fixed combination of cinnarizine and dimenhydrinate

International Tinnitus Journal

Volumn 14, Issue 1, 2008, Pages 57-67

  Otto, Volker ^a,b   Fischer, Bernhard ^a,c   Schwarz, Mario ^d   Baumann, Wolfgang ^d   Preibisch Effenberger, Rudolf ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b Schönebecker Kreiskrankenhaus   (Germany)

^c MarienHospital Osnabruck   (Germany)

^d Hennig Arzneimittel ^*  (Germany)

Author keywords

Betahistine; Cinnarizine; Dimenhydrinate; Vertebrobasilar insufficiency; Vertigo

Indexed keywords

BETAHISTINE DIMESILATE; CINNARIZINE; CINNARIZINE PLUS DIMENHYDRINATE; DIMENHYDRINATE; PLACEBO;

ADULT; ARTICLE; BULBAR PARALYSIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRANIOCORPOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEARING IMPAIRMENT; HUMAN; IMAGING; MALE; NYSTAGMUS; OPHTHALMOPLEGIA; PATIENT ASSESSMENT; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TINNITUS; TREATMENT DURATION; TREATMENT OUTCOME; UNTERBERGER TEST; VERTEBROBASILAR INSUFFICIENCY; VERTIGO; VESTIBULAR TEST; VISUAL IMPAIRMENT;

EID: 46049102012     PISSN: 09465448     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Haid CT. Vestibularisprüfung und vestibuläre Erkrankungen. Ein Leitfaden für Praxis und Klinik zur Diagnostik und Therapie von Schwindel und Gleichgewichtsstörungen. Berlin: Springer-Verlag, 1990.
2. Smith DB. Dizziness: The History and Physical Examination. In IK Arenberg (ed), Dizziness and Balance Disorders. Amsterdam: Kugler Publications, 1993:3-10.
3. Stoll W, Matz DR, Most E, Rudolf GAE. Schwindel und Gleichgewichtsstörungen, 3rd ed. Stuttgart: Thieme Verlag, 1998.
4. Glasscock ME III, Cueva RA, Thedinger BA. Handbook of Vertigo. New York: Raven Press, 1990.
5. Baloh RW. The dizzy patient. Postgrad Med 105:161-172, 1999.
6. Haid CT. Schwindel im Alter - diagnostik und therapie. Med Welt 49:581-591, 1998.
7. Lalwani AK. Vertigo, Dysequilibrium, and Imbalance with Aging. In RK Jackler, DE Brackmann (eds), Neurotology. St. Louis: Mosby-Year Book Inc., 1994:527-534.
8. Doss A, Phatouros CC. Vertebrobasilar insufficiency. Curr Treat Options Cardiovasc Med 8:111-119, 2006.
9. Welsh LW, Welsh JJ, Lewin B. Basilar artery and vertigo. Ann Otol Rhinol Laryngol 109:615-622, 2000.
10. Yamasoba T, Kikuchi S, Higo R. Deafness associated with vertebrobasilar insufficiency. J Neurol Sci 187:69-75, 2001.
11. Kumar A, Mafee M, Dobben G, et al. Diagnosis of vertebrobasilar insufficiency: Time to rethink established dogma? Ear Nose Throat J 77:966-974, 1998.
12. Wackym PA, Blackwell KE, Nyerges AM. Pharmacotherapy of Vestibular Dysfunction. In RK Jackler, DE Brackmann (eds), Neurotology. St. Louis: Mosby-Year Book, 1994:543-553.
13. Krämer G, Hopf H-C. Schwindel - Therapie aus neurologischer Sicht. Z Allg Med 64:483-491, 1988.
14. Oosterveld WJ. Vertigo. Current concepts in management. Drugs 30:275-283, 1985.
15. Kaźmierczak H, Pawlak-Osińska K, Kaźmierczak W. Betahistine in vertebrobasilar insufficiency. Int Tinnitus J 10:191-193, 2004.
16. Godfraind T, Towse G, van Nueten JM. Cinnarizine - A selective calcium entry blocker. Drugs Today 18:27-42, 1982.
17. Oosterveld WJ. Cinnarizine in the Vertiginous Syndrome. In G Towse (ed), Cinnarizine and the Vertiginous Syndrome. International Congress and Symposium Series No. 33. London: Royal Society of Medicine and Academic Press Inc., 1979:29-37.
18. Nilles R. A direct effect of calcium antagonists in the inner ear: Blockade of abnormal calcium increase in outer hair cells of the guinea pig. HNO 43:716-723, 1995.
19. Jaju BP, Wang SC. Effects of diphenhydramine and dimenhydrinate on vestibular neuronal activity of cat: A search for the locus of their antimotion sickness action. J Pharmacol Exp Ther 176:718-724, 1971.
20. Kukwa L. Selektive pharmakotherapeutische Stammhirndämpfung, 2nd ed. Hamburg: Edition m + p dr. Werner Rudat, 1981:9-14.
21. Sitzer G. Das Symptom Schwindel bei zerebrovaskulärer Insuffizienz. Medwelt 37:208-210, 1986.
22. Schmitz P. Therapie des vestibulären Schwindels. Ärztliche Praxis 34:1887-1891, 1979.
23. Halama P. Erfahrungen bei der Therapie des vestibulären und zerebralen Schwindels mit Arlevert. Therapiekontrolle mittels Kraniokorpographie. Therapiewoche 35:1422-1426, 1985.
24. Lowatscheff K. Therapie des Altersschwindels in der Praxis. Ergebnis einer offenen multizentrischen Studie. Therapiewoche 35:157-159, 1985.
25. Pytel J, Nagy G, Tóth A, et al. Fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: A double-blind, randomized, single actives- and placebo-controlled 3-center parallel group 4-week clinical study in 246 adult patients. Clin Ther 29:84-98, 2007.
26. Novotný M, Kostřica R. Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière's disease: A randomized, double-blind, parallel group clinical study. Int Tinnitus J 8:115-123, 2002.
27. Círek Z, Schwarz M, Baumann W, Novotný M. Efficacy and tolerability of a fixed combination of cinnarizine and dimenhydrinate versus betahistine in the treatment of otogenic vertigo - a double-blind, randomised clinical study. Clin Drug Invest 25:377-389, 2005.
28. Scholtz AW, Schwarz M, Baumann W, et al. Treatment of vertigo due to acute unilateral vestibular loss with a fixed combination of cinnarizine and dimenhydrinate: A double-blind, randomized, parallel-group clinical study. Clin Ther 26:866-877, 2004.
29. Schremmer D, Bognar-Steinberg I, Baumann W, Pytel J. Efficacy and tolerability of a fixed combination of cinnarizine and dimenhydrinate in treatment of vertigo - analysis of data from five randomised, double-blind clinical studies. Clin Drug Invest 18:355-368, 1999.
30. Novotný M, Kostřica R, Círek Z. The efficacy of Arlevert therapy for vertigo and tinnitus. Int Tinnitus J 5:60-62, 1999.
31. Brandt T. Differentialdiagnose klinischer Schwindelformen [editorial]. Munch Med Wochenschr 127:1137-1140, 1985.
32. Martinez DM. The effect of Serc (betahistine hydrochloride) on the circulation of the inner ear in experimental animals. Acta Otolaryngol Suppl 305:29-47, 1972.
33. Snow JB, Suga F. Control of the microcirculation of the inner ear. Otolaryngol Clin North Am 8:455-466, 1975.
34. Timmerman H. Histamine agonists and antagonists. Acta Otolaryngol Suppl 479:5-11, 1991.
35. Unemoto H, Sasa M, Takaori S, et al. Inhibitory effect of betahistine on polysynaptic neurons in the lateral vestibular nucleus. Arch Otorhinolaryngol 236:229-236, 1982.
36. Fischer AJ. Histamine in the treatment of vertigo. Acta Otolaryngol Suppl 479:24-28, 1991.
37. Arab SF, Düwel P, Jüngling E, et al. Inhibition of voltage-gated calcium currents in type II vestibular hair cells by cinnarizine. Naunyn Schmiedebergs Arch Pharmacol 369: 570-575, 2004.
38. Düwel P, Haasler T, Jüngling E, et al. Effects of cinnarizine on calcium and pressure-dependent potassium currents in guinea pig vestibular hair cells. Naunyn Schmiedebergs Arch Pharmacol 371:441-448, 2005.
39. Hofferberth B. Calcium entry blockers in the treatment of vertebrobasilar insufficiency. Eur Neurol 25(suppl 1):80-85, 1986.
40. Hofferberth B. Schwindel. Diagnostik und Therapie aus neurologischer Sicht. Med Monatsschr Pharm 11:79-84, 1988.
41. Fujimoto S, Masashi S, Takaori S, Matsuoka I. Selective effect of cinnarizine on the vestibular nucleus neurons. Arch Otorhinolaryngol 221:37-45, 1978.